These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9375283)

  • 21. PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome.
    Raijmakers R; Renz M; Wiemann C; Egberts WV; Seelig HP; van Venrooij WJ; Pruijn GJ
    Arthritis Rheum; 2004 Feb; 50(2):565-9. PubMed ID: 14872500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis.
    Svegliati S; Spadoni T; Moroncini G; Gabrielli A
    Free Radic Biol Med; 2018 Sep; 125():90-97. PubMed ID: 29694853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmunity as a secondary phenomenon in scleroderma (and so-called human adjuvant disease).
    Stone OJ
    Med Hypotheses; 1991 Feb; 34(2):127-30. PubMed ID: 2041486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies against PDGF receptor in scleroderma.
    Tan FK
    N Engl J Med; 2006 Jun; 354(25):2709-11. PubMed ID: 16790706
    [No Abstract]   [Full Text] [Related]  

  • 25. Association of the autoimmune disease scleroderma with an immunologic response to cancer.
    Joseph CG; Darrah E; Shah AA; Skora AD; Casciola-Rosen LA; Wigley FM; Boin F; Fava A; Thoburn C; Kinde I; Jiao Y; Papadopoulos N; Kinzler KW; Vogelstein B; Rosen A
    Science; 2014 Jan; 343(6167):152-7. PubMed ID: 24310608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications.
    Shah AA; Rosen A
    Curr Opin Rheumatol; 2011 Nov; 23(6):530-5. PubMed ID: 21825998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An antigenic region of topoisomerase I in DNA polymerase chain reaction-generated fragments recognized by autoantibodies of scleroderma patients.
    Piccinini G; Cardellini E; Reimer G; Arnett FC; Durban E
    Mol Immunol; 1991; 28(4-5):333-9. PubMed ID: 1712070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scleroderma: a disease related to damaged proteins?
    Peng SL; Fatenejad S; Craft J
    Nat Med; 1997 Mar; 3(3):276-8. PubMed ID: 9055850
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-CENPI autoantibodies in scleroderma patients with features of autoimmune liver diseases.
    Hamdouch K; Rodríguez C; Pérez-Venegas J; Rodríguez I; Astola A; Ortiz M; Yen TJ; Bennani M; Valdivia MM
    Clin Chim Acta; 2011 Nov; 412(23-24):2267-71. PubMed ID: 21888900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xenobiotic-induced recruitment of autoantigens to nuclear proteasomes suggests a role for altered antigen processing in scleroderma.
    Chen M; von Mikecz A
    Ann N Y Acad Sci; 2005 Jun; 1051():382-9. PubMed ID: 16126980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies in pathology and cell biology.
    Tan EM
    Cell; 1991 Nov; 67(5):841-2. PubMed ID: 1959131
    [No Abstract]   [Full Text] [Related]  

  • 32. Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension.
    Ulanet DB; Wigley FM; Gelber AC; Rosen A
    Arthritis Rheum; 2003 Feb; 49(1):85-92. PubMed ID: 12579598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-cardiolipin antibodies and other immunological disorders in patients with systemic scleroderma].
    Speranskiĭ AI; Riazantseva TA; Guseva NG; Melkumova KL; Ivanova SM
    Revmatologiia (Mosk); 1990; (3):11-4. PubMed ID: 2098888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scleroderma.
    Gabrielli A; Avvedimento EV; Krieg T
    N Engl J Med; 2009 May; 360(19):1989-2003. PubMed ID: 19420368
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-endothelial cell antibodies in systemic sclerosis.
    Mihai C; Tervaert JW
    Ann Rheum Dis; 2010 Feb; 69(2):319-24. PubMed ID: 20107031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Disorders of cellular immunity in systemic scleroderma].
    Sierakowski SJ; Kucharz EJ
    Przegl Lek; 1988; 45(7):592-7. PubMed ID: 3070641
    [No Abstract]   [Full Text] [Related]  

  • 37. Novel nucleolar antigens in autoimmune disease.
    Busch H; Busch RK; Black A; Chan PK; Chatterjee A; Durban E; Freeman J; Ochs R; Reichlin M; Tan EM
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():70-7. PubMed ID: 2441047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.
    Baroni SS; Santillo M; Bevilacqua F; Luchetti M; Spadoni T; Mancini M; Fraticelli P; Sambo P; Funaro A; Kazlauskas A; Avvedimento EV; Gabrielli A
    N Engl J Med; 2006 Jun; 354(25):2667-76. PubMed ID: 16790699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of anti-Ku autoantibodies--a serologic marker of overlap syndrome?
    Mimori T
    Intern Med; 2002 Dec; 41(12):1096-8. PubMed ID: 12521194
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.